CRISPR Cure for Heart Disease: Groundbreaking Research Shows Promise

May 8, 2022

Heart disease is the leading cause of death for both men and women in the United States, accounting for one in every four deaths. But a new study offers hope for a cure, using the CRISPR gene editing tool. Researchers at Stanford University have successfully used CRISPR to delete a faulty gene that causes heart disease in mice. This is a groundbreaking discovery, and could lead to similar treatments for humans in the future.

“Our study is the first to show that CRISPR can be used to effectively treat a disease by correcting a genetic mutation,” said senior author Dr. Matthew Porteus, a professor of pediatrics and of genetics at Stanford University School of Medicine. “This approach has the potential to be used for many other diseases caused by single-gene mutations.”

The study was published in the journal Nature Medicine.

This is an exciting development in the fight against heart disease, and could lead to new treatments for other diseases as well. CRISPR is a powerful tool that can be used to correct genetic defects, and this study shows its potential for treating disease.

First Tests in Humans

In a recent publishing on, Peter Diamandis reports “the company has now moved into clinical trials and earlier this month a volunteer from New Zealand became the first person to undergo the therapy. Initially, the treatment will be given to 40 people with an inherited condition called familial hypercholesterolemia that leads to extremely high levels of LDL.

The reason for focusing on this group is that they are at high risk of dangerous heart disease, so the benefits of the therapy should outweigh any potential risks. But the hope is that ultimately this treatment could be rolled out as the standard approach for dealing with heart disease.”

Though the therapy is still in early phases, if it evolves successfully it will be one of the biggest innovations on human health and longevity.